GConferenceGridThe Conference Catalogue · Vol. 2026Folio № D98628
Of the Field

LSX Congress USA 2026

L

SX Congress USA is where biotech companies from emerging startups to later-stage firms meet investors and pharma partners to power the next stage of growth. Attendees engage in 1:1 partnering, focused discussions on capital raising, investment strategies, commercialisation and pharma partnerships in the US life sciences sector. With tailored tracks, network…

Visit the official site
12Voices
11Underwriters
0Exhibitors
3On the bill · sessions
23Companies · in total
§I

The Voices

Programmed at LSX, in alphabetical order.
Brian Goodman
Managing Director · Vida Ventures
Curt LaBelle
Managing Partner & Head, AXA IM Global Health Investment Fund · BNP Paribas Asset Management
Elena Diez Cecilia
Senior Director External Innovation DPDS · Johnson & Johnson
Frederic Scaerou
Head Global Business Development · Servier
Jennifer Schranz
SVP Global Head of Rare Diseases · Ipsen
Jessica Federer
Board Member · Angelini Ventures
Kiran Reddy
Senior Managing Director · Blackstone Life Sciences
Mankit Law
Senior Director – BD, Search & Evaluation · GSK
Rachel Strick
VP, Business Development & Acquisitions · AbbVie
Scott DeWire
Corporate SVP & Head of Global Business Development · Boehringer Ingelheim
Scott Miller
Executive Director, Alliance and Innovation Management · Eli Lilly
Tomoko Hanadate
Head of R&D Alliances, Business Development · Astellas Pharma Inc.
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
A&O Shearman
Brown Rudnick
CMS
Ernst & Young
Finnegan
Fish & Richardson
Foley Hoag
Insmed
McDermott Will & Schulte
Servier Monde
Skadden
§III

The Programme

Selected from 3 sessions on the bill.
  • 1:30pm - 3:00pm

    Biotech CEO Forum

    The Biotech CEO Forum is an exclusive gathering designed for CEOs of private-stage biotech companies, ranging from start-ups to growth-stage enterprises. This forum provides a conf…

    Biotech CEO Forum
  • 3:30pm - 5:00pm

    Fundraising Masterclass

    The Financing Masterclass is a focused session tailored for private-stage biotech companies seeking to secure funding and optimize their financial strategies. This masterclass will…

    Fundraising Masterclass
  • 3:30pm - 5:00pm

    Pharma Partnering Forum

    The Pharma Partnering Forum is a focused session designed to help biotech companies understand the intricacies of partnering with pharmaceutical companies. This forum provides biot…

    Pharma Partnering Forum
Intermission
Part the Second · For the Buyer

An audience of 23 companies, parsed from the program.

23 companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
0All threespeak · spons · exh
11Sponsoringsponsor only
0Exhibitingexhibitor only
12Speakingspeaker only
02Fig. 02 — The Voices, by Seniority

83% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • Founder / Owner18%
  • VP-level325%
  • Director / Head of650%
  • Advisor / Investor18%
  • Other roles18%

Of 12 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01A&O ShearmanSp
  2. 02Brown RudnickSp
  3. 03CMSSp
  4. 04Ernst & YoungSp
  5. 05FinneganSp
  6. 06Fish & RichardsonSp
  7. 07Foley HoagSp
  8. 08InsmedSp
  9. 09McDermott Will & SchulteSp
  10. 10Servier MondeSp
  11. 11SkaddenSp
  12. 12AbbVie1V
  13. 13Angelini Ventures1V
  14. 14Astellas Pharma Inc.1V
04Fig. 04 — By Tier
unspecified11
100% of 11